Erlotinib and haemoglobin decreased Patient Reports February 11, 2012

Erlotinib Side Effects Report #5324241-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 23, 2007. Female patient, 77 years of age, weighting 136.0 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atrial fibrillation , blood creatine phosphokinase abnormal, dehydration, haematocrit decreased, haemoglobin decreased, loss of consciousness, mucosal inflammation, syncope, urinary tract infection . Erlotinib dosage: unknown. During the same period patient was treated with LORTAB, PRILOSEC, ASPIRIN, PLAVIX, DIFLUXAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4949561-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 09, 2006. Male patient, 52 years of age, weighting 224.9 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: body temperature increased, haematocrit decreased, haemoglobin decreased. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with AVASTIN, CISPLATIN, CIPROFLOXACIN, OXYCODONE, MIRALAX, PROTONIX. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4953770-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 13, 2006. Male patient, 52 years of age, weighting 224.9 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood bilirubin decreased, blood calcium decreased, haematocrit decreased, haemoglobin decreased, hypotension, leukocytoclastic vasculitis, orthostatic intolerance, platelet count decreased. Erlotinib dosage: 10 MG, QD, ORAL. During the same period patient was treated with AVASTIN, CISPLATIN, CIPROFLOXACIN, OXYCODONE, MIRALAX. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6090979-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2009. Male patient, 40 years of age, weighting 127.5 lb, was diagnosed with sinus disorder, squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood chloride decreased, chills, constipation , dehydration, haematocrit decreased, haemoglobin decreased, hyperhidrosis, hypophagia, nausea . Erlotinib dosage: 100MG/ORAL/DAILY. During the same period patient was treated with BEVACIZUMAB, ACETAMINOPHEN, DEXAMETHASONE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5107075-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 29, 2006. Male patient, 57 years of age, weighting 206.0 lb, was diagnosed with rectal cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, chills, colitis, diarrhoea, haematocrit decreased, haemoglobin decreased, infection , lymphopenia. Erlotinib dosage: 50 MG, DAYS 1-14 OF CYCLE (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, ATIVAN, COMPAZINE, FOLIC ACID, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5224439-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 12, 2007. Male patient, 88 years of age, was diagnosed with prostate cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood creatine increased, blood glucose increased, cardiac failure congestive, haemoglobin decreased, lung infiltration, nausea , pleural effusion, pulmonary oedema. Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with SYNTHROID, HUMULIN, FUROSEMIDE, COREG, LISINOPRIL, FERROUS SULPHATE, LEUPROLIDE ACETATE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5203396-6
Erlotinib side effect was reported by a Physician from PERU on Dec 21, 2006. Male patient, 74 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, diarrhoea, haemoglobin decreased, hypovolaemic shock, malabsorption, no therapeutic response. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized and became disabled. Patient died.

Erlotinib Side Effects Report #5477800-2
Erlotinib side effect was reported by a Physician from BELGIUM on Sept 17, 2007. Female patient, 70 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: deep vein thrombosis , haemoglobin decreased, interstitial lung disease, respiratory failure, somnolence. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, CAPOTEN, HYDROCODONE BITARTRATE, OMEPRAZOLE, PANCREATIN TRIPLE STRENGTH CAP, LYSOMUCIL, LANTUS. Patient was hospitalized. Patient died on 02/06/2006.

Erlotinib Side Effects Report #5420772-7
Erlotinib side effect was reported by a Physician from CANADA on Aug 01, 2007. Female patient, 69 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, clostridial infection, decreased appetite, failure to thrive, fatigue, haemoglobin decreased, oral intake reduced. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, BEVACIZUMAB, CRESTOR, GLYBURIDE, METFORMIN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5818454-2
Erlotinib side effect was reported by a Physician from SPAIN on July 03, 2008. Male patient, 60 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gastrointestinal disorder, haemoglobin decreased, upper gastrointestinal haemorrhage. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, VERAPAMIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5133149-9
Erlotinib side effect was reported by a Physician from AUSTRALIA on Oct 02, 2006. Male patient, 54 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bacterial infection , blood culture positive, disseminated intravascular coagulation, haemoglobin decreased. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, LAMIVUDINE, MAXOLON, PROCHLORPERAZINE MALEATE, ACETAMINOPHEN, TRAMADOL, NEXIUM. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5189471-3
Erlotinib side effect was reported by a Physician from AUSTRALIA on Nov 29, 2006. Male patient, 54 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bacillus infection, bacterial sepsis, disseminated intravascular coagulation, epistaxis, escherichia infection, gingival bleeding, haematocrit decreased, haemoglobin decreased, infusion related reaction. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, LAMIVUDINE, MAXOLON, PROCHLORPERAZINE MALEATE, ACETAMINOPHEN, TRAMADOL, NEXIUM. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5744847-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 02, 2008. Male patient, 75 years of age, weighting 164.9 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arthralgia, blood sodium decreased, candidiasis, confusional state, dehydration, haematocrit decreased, haemoglobin decreased, herpes simplex . Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with EVEROLIMUS, GLIMEPIRIDE, NORVASC, PRILOSEC, SENOKOT, MIRALAX, REGLAN, DOXYCYCLINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5360278-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 30, 2007. Female patient, 63 years of age, weighting 171.0 lb, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, body temperature increased, fibrin d dimer increased, glomerular filtration rate decreased, haematoma, haematoma infection, haemoglobin decreased, infusion site pain, international normalised ratio increased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with GEMCITABINE, REMERON, SYNTHROID, ZOCOR, ACIPHEX, ZOLOFT, DETROL LA, LOTREL. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5829432-1
Erlotinib side effect was reported by a Physician from UNITED STATES on July 15, 2008. Female patient, 55 years of age, weighting 145.5 lb, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, haemoglobin decreased, hyponatraemia, nausea , platelet count decreased, pyrexia. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with IRINOTECAN, AMLODIPINE, DOXAZOSIN, LISINOPRIL, METOPROLOL TARTRATE, OXYCONTIN, PROTONIX. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6083736-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 10, 2009. Male patient, 76 years of age, weighting 195.3 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal haemorrhage, haemoglobin decreased. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5877487-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 25, 2008. Male patient, 72 years of age, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anorexia, asthenia, atrial flutter, dehydration, fatigue, haematocrit decreased, haemoglobin decreased, sinus tachycardia. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, BACTRIM, ALBUTEROL, ESOMEPRAZOLE MAGNESIUM. Patient recovered.

Erlotinib Side Effects Report #5481997-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 10, 2007. Female patient, 71 years of age, weighting 166.9 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, diarrhoea, haemoglobin decreased, heart rate increased, leukopenia, mucosal inflammation, neutrophil count decreased. Erlotinib dosage: 100 MG. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, ACIPHEX, IMITREX, NAPROXEN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5916942-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 24, 2008. Male patient, 62 years of age, weighting 149.9 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, hypovolaemia, oesophagitis, platelet count decreased, white blood cell count decreased. Erlotinib dosage: (100 MG, QD) , ORAL. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, CARBOPLATIN, TAXOL. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5517708-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 29, 2007. Male patient, 93 years of age, weighting 117.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, chest pain , dehydration, haemoglobin decreased, weight decreased. Erlotinib dosage: 125 MG, QD, ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5277737-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 02, 2007. Female patient, 75 years of age, weighting 129.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood glucose increased, confusional state, convulsion, haemoglobin decreased, hypocalcaemia, hypokalaemia, hypomagnesaemia, mucosal dryness. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5398306-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 09, 2007. Female patient, 75 years of age, weighting 129.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood glucose increased, cellulitis , convulsion, electrolyte imbalance, haemoglobin decreased, hypocalcaemia, hypokalaemia, hypomagnesaemia. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5529998-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Female patient, 75 years of age, weighting 151.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain lower, diarrhoea, differential white blood cell count abnormal, disease progression, diverticulum intestinal, gallbladder disorder, haematocrit decreased, haemoglobin decreased, lymphadenopathy mediastinal. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with GEMCITABINE, NORVASC, BENAZEPRIL, LEXAPRO, DETROL, CLIRINEX, HYDROCHLOROTHIAZIDE, IRON POLYSACCHARIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5716934-1
Erlotinib side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on Apr 10, 2008. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoglobin decreased, interstitial lung disease, neutrophil count increased, pneumonia bacterial, respiratory failure. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with CEFTIZOXIME, CLINDAMYCIN. Patient was hospitalized. Patient died on 01/20/2008.


Erlotinib Side Effects Report #5248432-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 06, 2007. Male patient, 72 years of age, weighting 171.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, pneumonia , respiratory distress, respiratory failure. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with PREDNISONE, LISINOPRIL, ATENOLOL. Patient was hospitalized. Patient died on 01/18/2007.

Erlotinib Side Effects Report #5958888-9
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 04, 2008. Female patient, 71 years of age, weighting 139.8 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bone pain, cardio-respiratory arrest, haemoglobin decreased, musculoskeletal pain, respiratory tract haemorrhage, unresponsive to stimuli. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, ZOCOR, FLUOXETINE, OXYGEN, ESCITALOPRAM OXALATE, IRBESARTAN, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient died on 09/26/2008.

Erlotinib Side Effects Report #5041328-4
Erlotinib side effect was reported by a Physician from UNITED STATES on June 06, 2006. Female patient, 71 years of age, weighting 129.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: colitis ischaemic, constipation , dehydration, gastritis, gastrointestinal haemorrhage, haemoglobin decreased, intestinal obstruction, obstruction gastric, urinary tract infection . Erlotinib dosage: 150 MG, CYCLE 21 DAYS (OD), ORAL. During the same period patient was treated with COLACE, FERROUS SULPHATE, VICODIN. Patient was hospitalized. Patient died on 05/16/2006.

Erlotinib Side Effects Report #5042020-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 06, 2006. Female patient, 71 years of age, weighting 129.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , colitis ischaemic, constipation , dehydration, gastritis, haemoglobin decreased, intestinal obstruction, lower gastrointestinal haemorrhage, nausea . Erlotinib dosage: 150 MG, CYCLE 21 DAYS (OD), ORAL. During the same period patient was treated with COLACE, FERROUS SULPHATE, VICODIN. Patient was hospitalized. Patient died on 05/16/2006.

Erlotinib Side Effects Report #5721536-7
Erlotinib side effect was reported by a Physician from JAPAN on Apr 11, 2008. Female patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, non-small cell lung cancer, platelet count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MOBIC. Patient died on 03/23/2008.


Erlotinib Side Effects Report #5192758-1
Erlotinib side effect was reported by a Physician from SWITZERLAND on Dec 04, 2006. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, intestinal ischaemia, malignant pleural effusion, metastases to bone, metastases to liver, pathological fracture, pelvic fracture. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5678358-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 07, 2008. Female patient, 62 years of age, weighting 158.7 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral ischaemia, encephalopathy, haemoglobin decreased, lethargy, metastases to liver, muscular weakness, pyrexia. Erlotinib dosage: 150 MG (QD),ORAL; D. During the same period patient was treated with ASPIRIN, DEXAMETHASONE, INSULIN, LEVAMIR, LIPITOR, PAXIL, TRENTAL, PREMETREXED. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5332130-4
Erlotinib side effect was reported by a Physician from UNITED STATES on May 03, 2007. Female patient, 61 years of age, weighting 141.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood creatinine increased, blood phosphorus increased, diarrhoea, febrile neutropenia, haemoglobin decreased, hypokalaemia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5125147-6
Erlotinib side effect was reported by a Physician from ESTONIA on Sept 21, 2006. Male patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoglobin decreased, lung neoplasm malignant, malignant neoplasm progression, skin ulcer haemorrhage, soft tissue haemorrhage. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with FUROSEMIDE, SOTAHEXAL, ENALAPRIL MALEATE, IMDUR, IMOVANE, TRAMADOL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4899161-X
Erlotinib side effect was reported by a Health Professional from IRELAND on Jan 13, 2006. Female patient, 58 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, haemoglobin decreased, haemoptysis, red blood cell count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with ORAMORPH, MYCOSTATIN, NEXIUM, XANAX, MOBIC. Patient was hospitalized. Patient died on 01/05/2006.


Erlotinib Side Effects Report #5314283-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 10, 2007. Male patient, 56 years of age, weighting 110.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: catheter site haemorrhage, dizziness , haematemesis, haemoglobin decreased, rectal haemorrhage. Erlotinib dosage: 50 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, ISOSORBIDE MONONITRATE, LIPITOR, ZETIA, COREG, GLIPIZIDE, ALTACE, NEXIUM. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5748667-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 07, 2008. Male patient, 56 years of age, weighting 141.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ataxia , diplopia, disease progression, haemoglobin decreased, non-small cell lung cancer. Erlotinib dosage: unknown. During the same period patient was treated with ENZASTAURIN, TEGRETOL, KEPPRA, PROZAC, ZYRTEC, VYTORIN, LOTREL, EFFEXOR. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6121263-0
Erlotinib side effect was reported by a Health Professional from GERMANY on Feb 27, 2009. Male patient, 51 years of age, weighting 183.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoglobin decreased, mucosal haemorrhage, thrombocytopenia. Erlotinib dosage: (150 MG,QD),ORAL. During the same period patient was treated with PEMETREXED, FOLIC ACID, VITAMIN B12, DEXAMETHASONE, VOLTAREN, NOVALGIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5567652-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 30, 2007. Female patient, 47 years of age, weighting 168.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, haematocrit decreased, haemoglobin decreased, haemoptysis, red blood cell count increased, tobacco abuse. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, LIDOCAINE, CODEINE SUL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5616150-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 18, 2008. Female patient, 47 years of age, weighting 168.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, haemoptysis. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, LIDOCAINE, CODEINE SUL. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5875062-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 08, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile toxin test positive, dehydration, diarrhoea, haemoglobin decreased, nausea , pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5885500-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 15, 2008. Male patient, 47 years of age, weighting 185.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile toxin test positive, dehydration, diarrhoea, haemoglobin decreased, nausea , pyrexia. Erlotinib dosage: 150MG, ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5916946-9
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, dehydration, flatulence, haemoglobin decreased, ileus, pleural effusion, pleural fibrosis, small intestinal obstruction. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with DASATINB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5920061-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 30, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood potassium decreased, blood sodium decreased, clostridium difficile colitis, dehydration, haemoglobin decreased, ileus, nausea , pyrexia, small intestinal obstruction. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5944242-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 20, 2008. Male patient, 47 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: clostridium difficile colitis, dehydration, diarrhoea, haemoglobin decreased, nausea , pseudomembranous colitis, pyrexia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5947279-2
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 22, 2008. Male patient, 43 years of age, weighting 149.3 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood glucose increased, gastrointestinal haemorrhage, haemoglobin decreased, hypokalaemia. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, XANAX, LEXAPRO, COMPAZINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6120264-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 25, 2009. Female patient, 39 years of age, weighting 171.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, haemoptysis, platelet count decreased, white blood cell count decreased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BACTRIM DS, CLINDAMYCIN PHOSPHATE, ALBUTEROL, TYLENOL PM, PREDNISONE, DOCETAXEL, GEMCITABINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6140493-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 16, 2009. Female patient, 39 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, haemoptysis, thrombocytopenia, white blood cell count decreased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BACTRIM DS, CLINDAMYCIN PHOSPHATE, ALBUTEROL, TYLENOL WITH CODEINE, PREDNISONE, GEMCITABINE, ATOVAQUONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5829431-X
Erlotinib side effect was reported by a Physician from UNITED STATES on July 14, 2008. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dyspnoea, haematocrit decreased, haemoglobin decreased, pleuritic pain, productive cough. Erlotinib dosage: 150 MG, QD; ORAL. During the same period patient was treated with ALBUTEROL SULPHATE, ALPRAZOLAM, COMPAZINE, DUONEB, HYDROCODONE, PHENERGAN, SIMETHICONE, WELLBUTRIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5997996-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 14, 2008. Male patient, weighting 128.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, haemoglobin decreased, haemoptysis, hypoxia, international normalised ratio increased, lung consolidation, lymphadenopathy mediastinal, malignant neoplasm progression, prothrombin time prolonged. Erlotinib dosage: (150 MG,GD), ORAL. During the same period patient was treated with SORAFENIB, COUMADIN, MORPHINE, CHLORPROMAZINE, LASIX, DURAGESIC. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #6092991-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 10, 2009. Male patient, weighting 128.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, haemoglobin decreased, haemoptysis, hypoxia, malignant neoplasm progression, prothrombin time prolonged. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with COUMADIN, MORPHINE, CHLORPROMAZINE, LASIX, DURAGESIC, APIXTRA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5383679-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 30, 2007. Female patient, 63 years of age, weighting 106.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, large intestine perforation, neutropenia, peridiverticular abscess, platelet count decreased, pneumonia . Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, DURAGESIC, OXYCODONE, AMBIEN CR, DECADRON, COMPAZINE. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5215813-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 12, 2007. Male patient, 53 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, candidiasis, dysphagia, haemoglobin decreased, hiccups, mucosal inflammation, odynophagia, pharyngolaryngeal pain, pyrexia. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with AVASTIN, CISPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5088038-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Aug 14, 2006. Male patient, 53 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, condition aggravated, haemoglobin decreased, hiccups, neutrophil count decreased, odynophagia, pharyngolaryngeal pain, pyrexia. Erlotinib dosage: 100 MG QD ORAL. During the same period patient was treated with AVASTIN, CISPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5132589-1
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 10, 2006. Female patient, 51 years of age, weighting 144.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, ejection fraction decreased, haemoglobin decreased, heart valve insufficiency, hypotension, pain , respiratory distress, sepsis , ventricular dysfunction. Erlotinib dosage: 100 MG ORAL. During the same period patient was treated with BEVACIZUMAB, OXYCONTIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4881914-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 04, 2005. Female patient, 51 years of age, weighting 144.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoglobin decreased, liver function test abnormal, neutrophil percentage increased, pleural effusion, prothrombin time prolonged, pulmonary oedema, red blood cell count decreased, respiratory distress, ventricular dysfunction. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with AVASTIN, CISPLATIN, KLONOPIN, REMERON, RITALIN, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4889836-0
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 13, 2006. Female patient, 51 years of age, weighting 144.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ejection fraction decreased, haemoglobin decreased, hypotension, laboratory test interference, mitral valve incompetence, respiratory distress, sepsis , treatment noncompliance, tricuspid valve incompetence. Erlotinib dosage: 100 MG, ORAL. During the same period patient was treated with BEVACIZUMAB, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4947629-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 09, 2006. Female patient, 51 years of age, weighting 144.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ejection fraction decreased, haemoglobin decreased, hypotension, mitral valve incompetence, respiratory distress, sepsis , treatment noncompliance, ventricular dysfunction. Erlotinib dosage: 100 MG, ORAL. During the same period patient was treated with BEVACIZUMAB, OXYCONTIN, OXYCODONE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6091335-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 20, 2009. Male patient, 40 years of age, weighting 127.5 lb, was diagnosed with nasal sinus cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood chloride decreased, chills, constipation , dehydration, faecaloma, haematocrit decreased, haemoglobin decreased, hyperhidrosis, hypophagia. Erlotinib dosage: 100MG/ORAL/DAILY. During the same period patient was treated with BEVACIZUMAB, ACETAMINOPHEN, DEXAMETHASONE, ONDANSETRON, CISPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5715252-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 08, 2008. Male patient, 70 years of age, weighting 149.9 lb, was diagnosed with metastatic neoplasm and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: acth stimulation test abnormal, asthenia, blood glucose increased, blood thyroid stimulating hormone increased, cerebral atrophy, eye rolling, haematocrit increased, haemoglobin decreased, orthostatic hypotension. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL, FLOVENT, SYNTHROID, ASPIRIN, NIASPAN, VYTORIN. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #4910415-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 24, 2006. Male patient, 77 years of age, was diagnosed with lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cholelithiasis, haemangioma, haemoglobin decreased, international normalised ratio increased, lipase increased. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, HYDROCHLOROTHIAZIDE, MONOPRIL, WARFARIN, TOPROL, NEXIUM. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6051221-6
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Male patient, 76 years of age, weighting 118.8 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood creatinine increased, dermatitis acneiform, diarrhoea, dry skin, gait disturbance, haemoglobin decreased, lung adenocarcinoma, malignant neoplasm progression. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BETAMETHASONE, BACTRAMIN, ISOSORBIDE, ALLELOCK, PURSENNID, FAMOTIDINE, ISOSORBIDE MONONITRATE, MEXITIL. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #6132576-0
Erlotinib side effect was reported by a Physician from JAPAN on Mar 10, 2009. Male patient, 76 years of age, weighting 118.8 lb, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, blood creatinine increased, dermatitis acneiform, diarrhoea, dry skin, gait disturbance, haemoglobin decreased, lung adenocarcinoma, malignant neoplasm progression. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BETAMETHASONE, BACTRAMIN, ISOSORBIDE, ALLELOCK, PURSENNID, GASTER D, ISOSORBIDE MONONITRATE, MEXITIL. Patient was hospitalized. Patient died on 11/24/2008.

Erlotinib Side Effects Report #5176325-1
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 21, 2006. Male patient, 52 years of age, was diagnosed with laryngeal cancer, disease progression and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, diarrhoea, faecal incontinence, haemoglobin decreased, lobar pneumonia, loss of consciousness, malignant neoplasm progression, metastases to bone. Erlotinib dosage: 150 MG (QD); ORAL. During the same period patient was treated with CISPLATIN, DOCETAXEL, PEMETREXED. Patient was hospitalized. Patient died on 11/07/2006.

Erlotinib Side Effects Report #5194077-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 15, 2006. Male patient, 52 years of age, was diagnosed with laryngeal cancer, disease progression and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood sodium decreased, diarrhoea, faecal incontinence, haemoglobin decreased, hypoxia, international normalised ratio increased, laryngeal cancer. Erlotinib dosage: 150 MG (QD) ORAL. During the same period patient was treated with CISPLATIN, DOCETAXEL, PEMETREXED. Patient was hospitalized. Patient died on 11/07/2006.

Erlotinib Side Effects Report #5829433-3
Erlotinib side effect was reported by a Physician from UNITED STATES on July 15, 2008. Male patient, weighting 160.9 lb, was diagnosed with head and neck cancer  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gastrointestinal fistula, haematocrit decreased, haemoglobin decreased, post procedural haemorrhage. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4933916-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2006. Male patient, 54 years of age, weighting 148.6 lb, was diagnosed with glioblastoma multiforme and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: colostomy, diverticular perforation, enterococcal infection, febrile neutropenia, haematocrit decreased, haemoglobin decreased, mental status changes, platelet count decreased, pseudomonas infection. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with TEMOZOLOMIDE, DEXAMETHASONE, ESOMEPRAZOLE, LEXAPRO, KYTRIL, LEVAQUIN, ZYPREXA. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5509047-5
Erlotinib side effect was reported by a Physician from DENMARK on Oct 19, 2007. Male patient, 67 years of age, was diagnosed with gastrointestinal carcinoma, gastric cancer, pain , nausea , weight control  and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood alkaline phosphatase increased, diarrhoea, feeling abnormal, haemoglobin decreased, skin disorder. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, FENTANYL, ACETAMINOPHEN, MORPHINE, IMODIUM, PREDNISONE, SUPPLEMENT NOS, GABAPENTIN. Patient died on 09/10/2007.

Erlotinib Side Effects Report #5909742-X
Erlotinib side effect was reported by a Health Professional from DENMARK on Sept 18, 2008. Female patient, 57 years of age, was diagnosed with gastrointestinal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoglobin decreased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5515867-3
Erlotinib side effect was reported by a Physician from DENMARK on Oct 25, 2007. Female patient, 55 years of age, was diagnosed with gastrointestinal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: catheter related complication, dyspnoea, haemoglobin decreased, infection , thrombocytopenia. Erlotinib dosage: (150 MG), ORAL. During the same period patient was treated with BEVACIZUMAB, TENORMIN, ACETAMINOPHEN, WHOLE BLOOD. Patient was hospitalized. Patient recovered.


Erlotinib Side Effects Report #5529685-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Female patient, 44 years of age, was diagnosed with colon cancer metastatic, breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, constipation , dehydration, haemoglobin decreased, lethargy, nausea , platelet count decreased, pneumonia . Erlotinib dosage: 75 MG, QD, ORAL. During the same period patient was treated with VINFLUNINE, FENTANYL PATCH, OXYCODONE, KYTRIL, PROMETHAZINE, LEVSIN, MORPHINE, DIAZEPAM. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5194441-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 06, 2006. Male patient, 45 years of age, weighting 175.5 lb, was diagnosed with colon cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain , asthenia, diarrhoea, fatigue, haemoglobin decreased, nausea , neutrophil count decreased, oedema, ureteric obstruction. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with ATENOLOL, ATIVAN, DECADRON, EMEND, INSULIN, LISINOPRIL, LOVENOX. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4952300-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 02, 2006. Female patient, 58 years of age, weighting 121.9 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoglobin decreased, pericardial effusion, white blood cell count increased. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with EVEROLIMUS, HYDROCODONE BITARTRATE, TUSSIONEX, PHENYLTOLOXOAMINE, LEVAQUIN, IRON, CALTRATE, VITAMIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4967272-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 15, 2006. Female patient, 58 years of age, weighting 121.9 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chest discomfort, disease progression, dyspnoea, haemoglobin decreased, pericardial effusion, pleural effusion, white blood cell count increased. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with EVEROLIMUS, HYDROCODONE BITARTRATE, TUSSIONEX, PHENYLTOLOXAMINE, LEVAQUIN, IRON, CALTRATE, VITAMIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5736877-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Apr 21, 2008. Female patient, 58 years of age, weighting 179.9 lb, was diagnosed with adenocarcinoma pancreas and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arteriosclerosis coronary artery, atelectasis, disease progression, haemoglobin decreased, lymphadenopathy, platelet count decreased, pulmonary embolism . Erlotinib dosage: (100 MG, QD), ORAL. Patient recovered.

Erlotinib Side Effects Report #5766203-9
Erlotinib side effect was reported by a Physician from UNITED STATES on May 19, 2008. Female patient, 58 years of age, weighting 179.9 lb, was diagnosed with adenocarcinoma pancreas and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arteriosclerosis coronary artery, atelectasis, disease progression, haemoglobin decreased, platelet count decreased, pulmonary embolism . Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with LIPITOR, ZOFRAN, COMPAZINE, CLINDAMYCIN, DECADRON, LASIX, NASONEX, OXYCONTIN. Patient recovered.

Erlotinib Side Effects Report #5944222-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 20, 2008. Female patient, 71 years of age, weighting 139.8 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: back pain , bone pain, cardio-respiratory arrest, epistaxis, haematocrit decreased, haemoglobin decreased, musculoskeletal pain, respiratory tract haemorrhage, unresponsive to stimuli. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, ZOCOR, DOXYCYCLINE, OXYGEN. Patient died.

Erlotinib Side Effects Report #5861325-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 12, 2008. Male patient, 57 years of age, weighting 175.0 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, haematocrit decreased, haemoglobin decreased, post procedural haemorrhage, prothrombin time prolonged. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with BEVACIZUMAB, FLOUROURACIL, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5861325-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 12, 2008. Male patient, 57 years of age, weighting 175.0 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, haematocrit decreased, haemoglobin decreased, post procedural haemorrhage, prothrombin time prolonged. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, PACLITAXEL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5194440-3
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Dec 07, 2006. Female patient, 51 years of age, weighting 130.7 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoglobin decreased, infection , lymphopenia, neutrophil count decreased, platelet count abnormal, white blood cell count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CISPLATIN, WELLBUTRIN, ZOLOFT. Patient was hospitalized. Patient recovered.